<?xml version="1.0" encoding="UTF-8"?>
<p id="Par59">Failure to a previous anti-HCV treatment was reported in 32 patients (22.2%), the majority among patients in treatment with anxiolitycs and antidepressant (28.7% vs. 7.0%, 
 <italic>p</italic> = 0.004). Among the HCV treatment-experienced subjects, one had experienced failure with a previous DAA-based regimen.
</p>
